Meaghan Stirn, MBA

Epicentrx
La Jolla, California, United States

Presentation(s):

• Paper 16 - ACTIVITY OF ADAPT-001 WITH A CHECKPOINT INHIBITOR IN ANGIOSARCOMA PATIENTS REFRACTORY TO CHECKPOINT INHIBITION

  Thursday, November 13, 2025
  1:30 PM - 3:00 PM EST

  Disclosure information not submitted.